hCD19/hCD3EDG(BALB/c)
品系全名
BALB/cAnSmoc-Cd19em(hCD19)Cd3etm1(hCD3E)Cd3dtm1(hCD3D)Cd3gtm1(hCD3G)Smoc
目錄號
NM-XA-240066
品系狀態(tài) 胚胎凍存
品系描述
驗證數(shù)據(jù)
Fig.1 Detection of immune phenotype in WT BALB/c and HO/HO hCD3EDG/hCD19 mice.(male, n=3)
Fig.2 Detection of phenotype in Peripheral blood in WT BALB/c and HO/HO hCD3EDG/hCD19 mice.
Fig.3 Detection of phenotype in Spleen in WT BALB/c and HO/HO hCD3EDG/hCD19 mice.
Fig.4 Detection of phenotype in Lymph node in WT BALB/c and HO/HO hCD3EDG/hCD19 mice.
Fig.5 Blinatumomab injections were repeated daily for 5 days and immune cells in the PB of mice after therapy were measured by flow cytometry(n=6). Average?± SEM;*P<0.05,**P<0.01,***P<0.001;(Student' s t test)
你也可能感興趣
Cre-ERT2在無Tamoxifen誘導的情況下,在細胞質內處于無活性狀態(tài);當Tamoxifen誘導后,Tamoxifen的代謝產物4-OHT(雌激素類似物)與ERT結合,可使Cre-ERT2進核發(fā)揮Cre重組酶活性。
查看